$PTI The key to PTI Triplet Study Phase 2 success will come from increase dosage and lengthen time from 14 day to 28 day. But are you aware during 14 day there was no plateau meaning could go higher in overall improvement in lung function. After achieving 8% on prior study, then easy see why Bulls are confident PTI will achieve 10% ppFEV1 marking a strong correlation to VRTX. This will be key driver in December.. 👇 👉“With no plateau in ppFEV1 improvement reached over 14 days in our triplet combination study, we look forward to studying what we believe are the optimal doses for our corrector and potentiator through longer duration trials in subjects who are not predisposed to rapid pulmonary decline”
  • 8
  • 1